Covaxin has proven to be ‘safe well-tolerated and highly immunogenic’ in children

NEW DELHI: Bharat Biotech’s Covaxin has proven to be ‘safe, well-tolerated, and highly immunogenic’ in children in Phase II/III studies, the results of which are…